乳腺病理质量保证:修订报告复核的经验教训
72%修订为非解释性错误,27.9%为误解释,其中14例为主要诊断改变(占全部修订11.5%)。复核修订报告有助于识别错误频率、类型和检测方法。
要点
- 乳腺病理修订报告中72%为非解释性错误,27.9%为误解释。
- 主要诊断改变占全部修订11.5%,包括漏诊微浸润和微小转移等。
- 因辅助研究等原因重新审阅病例时是病理医生复核诊断的良机。
核心结论
- 复核修订报告是识别错误频率、类型和检测方法的有用手段。
- 每当因辅助研究或其他原因重新审阅病例时,都是外科病理医生重新考虑自己或他人诊断的机会。
研究设计与样本
- 回顾性识别某大型学术医学中心5年内所有乳腺手术标本的修订病理报告,并按既定分类法分类。
主要发现
- 122份修订报告中,88例(72%)为非解释性错误,包括58例报告缺陷、12例错误识别和3例标本缺陷。
- 34例(27.9%)归类为误解释,其中14例(占全部修订的11.5%)为主要诊断改变。
- 主要改变包括漏诊微浸润或小灶浸润、漏诊微小转移、非典型导管增生过度诊断为导管原位癌、硬化性腺病中的导管原位癌误认为浸润癌、淋巴瘤误认为浸润癌、淀粉样变性误诊为脂肪坏死。
- 9例主要改变在受体研究解读时发现,未伴随临床后果。
- 3例伴随临床后果,且同一病理医生解读了相应的受体研究。
临床怎么用
- 乳腺病理诊断中应重视非解释性错误和误解释的识别与分类。
- 在因辅助研究或其他原因重新审阅病例时,主动复核诊断以减少误诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: -A review of amended pathology reports provides valuable information regarding defects in the surgical pathology process. OBJECTIVE: -To review amended breast pathology reports with emphasis placed on interpretative errors and their mechanisms of detection. DESIGN: -All amended pathology reports for breast surgical specimens for a 5-year period at a large academic medical center were retrospectively identified and classified based on an established taxonomy. RESULTS: -Of 12 228 breast pathology reports, 122 amended reports were identified. Most (88 cases; 72%) amendments were due to noninterpretative errors, including 58 report defects, 12 misidentifications, and 3 specimen defects. A few (34 cases; 27.9%) were classified as misinterpretations, including 14 major diagnostic changes (11.5% of all amendments). Among major changes, there were cases of missed microinvasion or small foci of invasion, missed micrometastasis, atypical ductal hyperplasia overcalled as ductal carcinoma in situ, ductal carcinoma in situ involving sclerosing adenosis mistaken for invasive carcinoma, lymphoma mistaken for invasive carcinoma, and amyloidosis misdiagnosed as fat necrosis. Nine major changes were detected at interpretation of receptor studies and were not associated with clinical consequences. Three cases were associated with clinical consequences, and of note, the same pathologist interpreted the corresponding receptor studies. CONCLUSIONS: -Review of amended reports was a useful method for identifying error frequencies, types, and methods of detection. Any time that a case is revisited for ancillary studies or other reasons, it is an opportunity for the surgical pathologist to reconsider one's own or another's diagnosis.
引用
- Harrison BT, Dillon DA, Richardson AL, et al. Quality Assurance in Breast Pathology: Lessons Learned From a Review of Amended Reports. Arch Pathol Lab Med. 2016. PMID: 27959581. doi:10.5858/arpa.2016-0018-OA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。